Mice Model Market Size, A Comprehensive Outlook and Forecast for 2026-2035

The global Mice Model Market was valued at USD 2.5 billion in 2025 and is projected to reach USD 6.9 billion by the end of 2035, expanding at a CAGR of 10.5% during the forecast period. The market is experiencing strong growth due to increasing utilization of laboratory mouse models in biomedical research, preclinical testing, oncology studies, genetic engineering, and personalized medicine development. The growing dependence on genetically engineered mice for translational research and therapeutic validation continues to accelerate market expansion worldwide.

The market has gained substantial momentum as pharmaceutical companies, biotechnology firms, academic institutions, and contract research organizations increasingly rely on mouse models to study human disease mechanisms, evaluate drug efficacy, and improve safety profiling. Rising investments in life sciences research and rapid advancements in genome-editing technologies are expected to further strengthen market demand over the coming decade.

Request Sample @ https://www.researchnester.com/sample-request-8337

Detailed Description and Industry Demand

The Mice Model Market comprises the development, breeding, supply, genetic modification, preservation, and commercialization of laboratory mice used in biomedical and pharmaceutical research. Mouse models are widely utilized because of their genetic similarity to humans, rapid reproductive cycles, controlled breeding capabilities, and suitability for disease modeling. These models are critical tools in oncology, immunology, metabolic disease research, neuroscience, infectious disease studies, and toxicology testing.

Mice models play a central role in modern drug discovery and translational medicine. Researchers utilize these models to replicate human disease conditions and evaluate therapeutic responses before clinical trials. The growing demand for personalized medicine and precision therapeutics has significantly increased the need for genetically engineered mouse models capable of mimicking specific genetic mutations and disease pathways.

Demand for mice model products and services is increasing due to several operational and scientific advantages. Mouse models are comparatively cost-effective when compared with larger laboratory animals, making them highly suitable for large-scale research programs. Their ease of handling and administration enables efficient laboratory experimentation and high-throughput screening processes. Long-term colony maintenance and cryopreservation capabilities further improve operational flexibility and reduce breeding costs. Additionally, rapid technological developments in gene editing, particularly CRISPR/Cas9-based engineering, have enhanced the precision and speed of developing customized mouse strains, further boosting industry demand.

Increasing prevalence of chronic diseases such as cancer, diabetes, cardiovascular disorders, autoimmune diseases, and neurological conditions has intensified global research activities, thereby supporting sustained market growth. Regulatory emphasis on preclinical safety validation and increasing outsourcing of animal model services to specialized providers are also contributing significantly to market expansion.

Most Important Growth Drivers and Restraint

Rising Prevalence of Chronic and Complex Diseases

The increasing global burden of cancer, metabolic disorders, neurological diseases, cardiovascular conditions, and autoimmune diseases is a major factor driving the demand for mice models. Pharmaceutical and biotechnology companies extensively utilize mouse models to understand disease progression, identify therapeutic targets, and validate drug candidates. Oncology research, in particular, has emerged as a major application area due to growing investments in immunotherapy and targeted therapeutics.

Advancements in Genetic Engineering Technologies

Rapid technological innovations such as CRISPR/Cas9 gene editing, embryonic stem cell manipulation, and transgenic engineering have transformed the mice model industry. These technologies enable the development of highly specialized mouse strains with precise genetic modifications, improving the reliability and efficiency of biomedical research. The ability to rapidly generate humanized and disease-specific mouse models has significantly accelerated drug discovery timelines.

Increasing Outsourcing to CROs and Specialized Providers

Pharmaceutical and biotechnology companies are increasingly outsourcing breeding, genetic engineering, cryopreservation, and preclinical research services to contract research organizations and specialized mouse model providers. Outsourcing reduces infrastructure costs, improves operational efficiency, and provides access to advanced expertise and specialized animal facilities. This trend is particularly strong among small and mid-sized biotechnology companies seeking cost-effective research solutions.

Key Restraint: Ethical Concerns and Regulatory Challenges

Ethical concerns associated with animal testing and stringent regulatory requirements related to laboratory animal welfare remain major restraints for the market. Governments and regulatory agencies across several countries are implementing stricter guidelines regarding animal handling, breeding conditions, and experimental procedures. Compliance with these regulations increases operational costs and may limit research flexibility for certain organizations.

Detailed Segment Analysis

Segment Analysis by Type

Inbred Mice

Inbred mice remain one of the most widely used mouse model categories due to their genetic uniformity and reproducibility in experimental outcomes. These models are heavily utilized in immunology, oncology, and toxicology studies where consistency is critical. Academic institutions and pharmaceutical companies continue to rely on inbred strains for fundamental biomedical research and drug screening programs.

Outbred Mice

Outbred mice are preferred for studies requiring genetic diversity and broader biological variability. These models are commonly used in toxicology testing, pharmacology, and safety evaluation studies. Their ability to mimic population-level responses supports increasing adoption in translational and behavioral research.

Genetically Engineered Mice

Genetically engineered mice represent the fastest-growing segment due to increasing use in precision medicine, gene therapy, and disease-specific research. These models include transgenic, knockout, knock-in, and humanized mice developed using advanced gene-editing technologies. Demand is particularly strong in oncology, immunotherapy, and rare disease research.

Hybrid/Congenic Mice

Hybrid and congenic mice are increasingly utilized in comparative genetics and disease susceptibility studies. These models offer advantages in studying complex polygenic disorders and improving experimental reproducibility across research programs.

Surgically Modified Mice

Surgically modified mice are used in specialized biomedical applications including cardiovascular studies, neurological research, transplantation studies, and metabolic disease experiments. Demand is supported by growing interest in advanced surgical modeling techniques and organ-specific disease investigations.

Spontaneous Mutant Mice

Spontaneous mutant mice are valuable in understanding naturally occurring genetic disorders and rare disease mechanisms. These models are widely utilized in genetic and developmental biology research due to their unique mutation profiles and disease phenotypes.

Segment Analysis by Service

Breeding and Rederivation Services

Breeding and rederivation services represent a major revenue-generating segment due to rising demand for pathogen-free colonies and customized breeding programs. Pharmaceutical companies increasingly outsource colony management to reduce operational burden and ensure compliance with laboratory standards.

Inbred Mice

Widely used for maintaining genetically stable research colonies and standardized testing programs.

Outbred Mice

Preferred for large-scale toxicology and pharmacological screening studies requiring biological variability.

Genetically Engineered Mice

Strong demand due to increasing development of customized disease models and therapeutic validation studies.

Hybrid/Congenic Mice

Growing adoption in comparative genomics and translational research programs.

Surgically Modified Mice

Utilized for advanced preclinical surgical modeling applications.

Spontaneous Mutant Mice

Important for genetic disorder and hereditary disease investigations.

Cryopreservation and Cryorecovery Services

Cryopreservation services are witnessing substantial demand as research organizations seek long-term preservation of valuable mouse strains. These services help reduce colony maintenance costs and ensure genetic stability.

Inbred Mice

Commonly preserved for standardized research continuity.

Outbred Mice

Used to maintain diverse genetic resources for future studies.

Genetically Engineered Mice

High-value segment due to increasing number of engineered strains requiring long-term storage.

Hybrid/Congenic Mice

Important for preserving complex genetic backgrounds.

Spontaneous Mutant Mice

Preserved for rare disease and mutation-based research applications.

Genetic Testing Services

Genetic testing services are essential for validating genetic modifications and ensuring strain authenticity.

Inbred Mice

Used for strain verification and quality assurance.

Genetically Engineered Mice

Extensively utilized for mutation confirmation and genotype validation.

Hybrid/Congenic Mice

Supports background characterization and breeding accuracy.

Spontaneous Mutant Mice

Critical for identifying naturally occurring mutations.

Model-in-Licensing Services

Model licensing services are expanding due to increasing commercialization of proprietary mouse models and intellectual property protection.

Inbred Mice

Licensed for specialized research programs.

Genetically Engineered Mice

Highly commercialized segment with strong demand from pharmaceutical developers.

Hybrid/Congenic Mice

Used in collaborative genetic research projects.

Spontaneous Mutant Mice

Licensed for rare disease and specialty therapeutic research.

Other Services

Additional services include microbiome profiling, phenotyping, surgical procedures, colony management, and consulting support.

Segment Analysis by Technology

CRISPR/Cas9

CRISPR/Cas9 technology has revolutionized the mice model industry by enabling rapid, precise, and cost-effective genetic modifications. This technology significantly reduces model development timelines and supports the creation of highly targeted disease models.

Microinjection

Microinjection remains a widely adopted technology for introducing genetic material into embryos. It continues to play a critical role in transgenic model development and reproductive biotechnology.

Embryonic Stem Cell Injection

Embryonic stem cell injection technology is extensively used for generating knockout and knock-in mouse models. The technology remains highly important in developmental biology and genetic engineering research.

Nuclear Transfer

Nuclear transfer technology supports cloning and advanced genetic manipulation applications. Although relatively specialized, it remains valuable in regenerative medicine and stem cell research.

Other Technologies

Other technologies including TALENs, zinc-finger nucleases, and advanced breeding systems continue to support innovation in mouse model generation and functional genomics research.

Segment Analysis by Application

Drug Discovery & Development

Drug discovery and development remains the dominant application area due to extensive use of mouse models in efficacy testing, toxicology studies, and preclinical validation.

Basic & Cancer Research

Cancer research represents a highly significant segment driven by increasing demand for tumor modeling, immuno-oncology studies, and targeted therapy development.

Immunology & Inflammation Studies

Mouse models are extensively utilized in autoimmune disease research, vaccine development, and inflammatory disorder investigations.

Metabolic Disease Research

Growing prevalence of obesity and diabetes is driving increased use of mouse models in metabolic pathway analysis and therapeutic development.

Cardiovascular Studies

Cardiovascular research applications continue to expand with increasing focus on heart failure, hypertension, and vascular disease studies.

Neurology & Behavior Studies

Neurological mouse models are widely used in Alzheimer’s disease, Parkinson’s disease, autism spectrum disorders, and behavioral neuroscience research.

Other Disease Research

Additional applications include infectious diseases, respiratory disorders, reproductive health, and rare genetic conditions.

Segment Analysis by End User

Pharmaceutical & Biotechnology Companies

Pharmaceutical and biotechnology companies represent the largest end-user segment due to increasing investments in drug development and precision medicine programs.

Drug Discovery & Development

Strong reliance on mouse models for candidate screening and preclinical evaluation.

Basic & Cancer Research

Increasing adoption in oncology pipeline development and biomarker discovery.

Immunology & Inflammation Studies

Widely utilized in immunotherapy and autoimmune disease research.

Metabolic Disease Research

Growing demand driven by diabetes and obesity drug development.

Cardiovascular Studies

Used in evaluating cardiac safety and therapeutic efficacy.

Neurology & Behavior Studies

Expanding use in neurodegenerative disease research.

Other Disease Research

Supports broader therapeutic innovation programs.

Academic & Research Institutions

Academic institutions utilize mouse models extensively for fundamental biological and translational research.

Contract Research Organizations (CROs)

CROs are experiencing increasing demand due to rising outsourcing trends among pharmaceutical and biotechnology companies.

Government & Non-profit Organizations

Government-funded research institutes and non-profit organizations support disease-focused studies and public health initiatives using mouse models.

Segment Analysis by Disease Type

Oncology

Oncology remains the largest disease segment due to increasing global cancer research activities and immunotherapy development.

Metabolic Diseases

Metabolic disease research is expanding rapidly with growing focus on obesity, diabetes, and metabolic syndrome studies.

Neurological Diseases

Neurological disease models are increasingly important in neurodegenerative and behavioral disorder research.

Immunological Diseases

Demand for immunological disease models continues to rise due to increasing autoimmune and inflammatory disease prevalence.

Cardiovascular Diseases

Cardiovascular models are widely used for studying hypertension, atherosclerosis, and heart failure.

Infectious Diseases

Mouse models remain critical for vaccine development and infectious disease pathogenesis research.

Other Diseases

Additional disease applications include respiratory disorders, reproductive diseases, and rare genetic conditions.

Regional Insights

North America

North America dominates the Mice Model Market due to strong pharmaceutical research infrastructure, advanced biotechnology capabilities, and substantial research funding. The region benefits from high adoption of genetically engineered mouse models and strong presence of leading market participants. Increasing investments in oncology research, immunotherapy development, and personalized medicine continue to support regional market growth. The United States remains the primary contributor due to extensive biomedical research activities and widespread outsourcing to CROs.

Europe

Europe represents a significant market driven by expanding biomedical research programs, government-funded scientific initiatives, and increasing demand for transgenic mouse models. Countries such as Germany, France, and the United Kingdom maintain strong research ecosystems and advanced laboratory infrastructure. Growing focus on rare disease research and precision medicine is further supporting regional demand. Ethical regulations related to animal welfare are encouraging the adoption of advanced breeding and cryopreservation technologies.

Asia-Pacific (APAC)

Asia-Pacific is emerging as the fastest-growing regional market due to rapidly expanding pharmaceutical manufacturing, increasing biotechnology investments, and growing clinical research activities. China and Japan are major contributors, supported by rising government funding for life sciences research and expanding CRO industries. The region is witnessing increasing adoption of CRISPR-based mouse model technologies and growing collaboration between international pharmaceutical companies and regional research organizations.

Key Players in the Market

Key players operating in the Mice Model Market include Charles River Laboratories, The Jackson Laboratory, Envigo, Taconic Biosciences, Janvier Labs, genOway, TransCure bioServices, Ingenious Targeting Laboratory, PolyGene, Crown Bioscience, Cyagen Biosciences, Shanghai Model Organisms Center, Harbour BioMed, Ozgene Pty Ltd, Pharmalegacy, CLEA Japan, Inc., Japan SLC, Inc., Daegu Gyeongbuk Medical Innovation Foundation, Biocytogen, and Inotiv.

Access Detailed Report @ https://www.researchnester.com/reports/mice-model-market/8337

Research Nester Analytics is a leading service provider for strategic market research and consulting. We provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates, and executives make informed decisions regarding future marketing strategy, expansion, and investments. We believe every business can expand its horizon with the right guidance at the right time. Our out-of-the-box thinking helps clients navigate future uncertainties and market dynamics.

Contact for more Info:

AJ Daniel

Email: info@researchnester.com

U.S. Phone: +1 646 586 9123

U.K. Phone: +44 203 608 5919